Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:848272.
doi: 10.1155/2015/848272. Epub 2015 May 18.

Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?

Affiliations
Review

Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?

V Altabas. Int J Endocrinol. 2015.

Abstract

Cardiovascular complications are the most common complications of diabetes mellitus. A prominent attribute of diabetic cardiovascular complications is accelerated atherosclerosis, considered as a still incurable disease, at least at more advanced stages. The discovery of endothelial progenitor cells (EPCs), able to replace old and injured mature endothelial cells and capable of differentiating into healthy and functional endothelial cells, has offered the prospect of merging the traditional theories on the pathogenesis of atherosclerosis with evolving concepts of vascular biology. The literature supports the notion that EPC alterations are involved in the pathogenesis of vascular diseases in diabetics, but at present many questions remain unanswered. In this review the aspects linking endothelial progenitor cells to the altered vascular biology in diabetes mellitus are discussed.

PubMed Disclaimer

References

    1. Riddle M. C. Glycemic control and cardiovascular mortality. Current Opinion in Endocrinology, Diabetes & Obesity. 2011;18(2):104–109. doi: 10.1097/med.0b013e3283446b7e. - DOI - PubMed
    1. Mellbin L. G., Anselmino M., Rydén L. Diabetes, prediabetes and cardiovascular risk. European Journal of Cardiovascular Prevention and Rehabilitation. 2010;17(supplement 1):S9–S14. doi: 10.1097/01.hjr.0000368192.24732.2f. - DOI - PubMed
    1. Martín-Timón I., Sevillano-Collantes C., Segura-Galindo A., del Cañizo-Gómez F. J. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World Journal of Diabetes. 2014;5(4):444–470. - PMC - PubMed
    1. Stöhr R., Federici M. Insulin resistance and atherosclerosis: convergence between metabolic pathways and inflammatory nodes. Biochemical Journal. 2013;454(1):1–11. doi: 10.1042/bj20130121. - DOI - PubMed
    1. Polovina M. M., Potpara T. S. Endothelial dysfunction in metabolic and vascular disorders. Postgraduate Medicine. 2014;126(2):38–53. doi: 10.3810/pgm.2014.03.2739. - DOI - PubMed

LinkOut - more resources